Who has invested in HighTide Therapeutics?

No investors are named on the public record for HighTide Therapeutics yet.

HighTide Therapeutics Funding: $167M Raised, Series C (2020)

HighTide Therapeutics funding overview

HighTide Therapeutics is based in Shenzhen, China. HighTide Therapeutics has raised $167M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2020. The round record for HighTide Therapeutics runs through 2020; nothing later has been disclosed.

HighTide Therapeutics at a glance

Total raised: $167M
Latest round: Series C
Latest round date: December 2020
Headquarters: Shenzhen, China

Frequently asked about HighTide Therapeutics funding

How much has HighTide Therapeutics raised?: HighTide Therapeutics has raised $167M in total disclosed funding across the rounds on record.
Who has invested in HighTide Therapeutics?: No investors are named on the public record for HighTide Therapeutics yet.
What was the latest HighTide Therapeutics funding round?: The most recent disclosed round is a Series C, announced in December 2020.
Where is HighTide Therapeutics based?: HighTide Therapeutics is based in Shenzhen, China.
When did HighTide Therapeutics last raise?: The last disclosed HighTide Therapeutics round closed in December 2020 at Series C.

Totals shown for HighTide Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Shenzhen and the investors behind them below.

HighTide Therapeutics Funding: $167M Raised, Series C (2020)

HighTide Therapeutics funding overview

HighTide Therapeutics at a glance

Frequently asked about HighTide Therapeutics funding

Companies related to HighTide Therapeutics (18)

Browse related funding lists (3)